PATHOLOGY RESEARCH AND PRACTICE
Scope & Guideline
Empowering Researchers with Cutting-Edge Findings
Introduction
Aims and Scopes
- Molecular Pathology:
Research exploring the molecular mechanisms underlying diseases, including cancer genomics, epigenetics, and the role of non-coding RNAs in tumor progression. - Histopathological Studies:
Detailed examinations of tissue specimens to identify disease patterns, tumor characteristics, and their correlation with clinical outcomes. - Diagnostic Innovations:
Development and validation of novel biomarkers and diagnostic techniques, including immunohistochemical markers and next-generation sequencing applications. - Cancer Immunology:
Studies focused on the tumor microenvironment, immune evasion mechanisms, and the role of immune checkpoints in cancer progression and therapy. - Therapeutic Research:
Research on therapeutic targets, including drug resistance mechanisms, and the potential of novel treatment modalities such as immunotherapy and gene therapy.
Trending and Emerging
- Role of Non-coding RNAs:
Increasing research on non-coding RNAs, particularly their roles in cancer progression, chemoresistance, and as potential therapeutic targets, showcases the expanding understanding of RNA biology in pathology. - Tumor Microenvironment Studies:
A growing emphasis on the tumor microenvironment, including interactions between cancer cells and stromal components, is evident, highlighting its significance in cancer biology and treatment responses. - Artificial Intelligence and Digital Pathology:
The integration of artificial intelligence and machine learning techniques in pathology for diagnostic purposes is a rapidly emerging theme, showcasing the potential for enhanced accuracy and efficiency in diagnostics. - Immunotherapy and Cancer Treatment:
Research focusing on immunotherapeutic strategies, including the exploration of immune checkpoint inhibitors and their roles in various cancers, is gaining momentum, reflecting a significant shift in cancer treatment paradigms. - Personalized Medicine Approaches:
Emerging studies on personalized medicine in pathology, particularly the use of genetic and epigenetic profiling to tailor treatments, are becoming increasingly prevalent.
Declining or Waning
- Traditional Histopathology Techniques:
There has been a noticeable decrease in studies emphasizing traditional histopathological techniques without molecular or genetic components, as the field moves towards more integrative approaches that combine histology with molecular data. - Single Disease Focus:
Research centered exclusively on individual diseases without consideration of broader implications or multi-disease comparisons is becoming less common, as interdisciplinary studies gain traction. - Basic Pathophysiology Studies:
Papers focusing solely on basic pathophysiological mechanisms without direct clinical or therapeutic relevance are less frequently published, indicating a trend towards translational research.
Similar Journals
PATHOLOGY INTERNATIONAL
Exploring the Depths of Pathological SciencePATHOLOGY INTERNATIONAL, published by WILEY, stands as a distinguished journal in the field of pathology and forensic medicine, serving as an essential resource for researchers, clinicians, and students alike. With its ISSN 1320-5463 and E-ISSN 1440-1827, PATHOLOGY INTERNATIONAL has established itself since its inception in 1951, navigating through an evolving landscape in medical science with insights and breakthroughs up to 2024. It holds a commendable Q2 ranking in both the Medicine (miscellaneous) and Pathology and Forensic Medicine categories, indicating its robust influence and quality within these fields, as evidenced by its placement in the 70th percentile of Scopus rankings. While currently not an open-access journal, it provides access options that ensure valuable research remains available to the academic community. PATHOLOGY INTERNATIONAL commits to advancing the discipline through pioneering research articles, comprehensive reviews, and expert opinions that push the boundaries of understanding in pathology, thereby supporting the enhancement of diagnostic and therapeutic practices.
CARDIOVASCULAR PATHOLOGY
Leading the way in cardiovascular research excellence.CARDIOVASCULAR PATHOLOGY, published by Elsevier Science Inc, is a distinguished journal dedicated to the dissemination of high-quality research in the fields of cardiology, pathology, and cardiovascular medicine. With an ISSN of 1054-8807 and an E-ISSN of 1879-1336, this journal has established itself as a vital resource for researchers, clinicians, and students alike. It is positioned in the Q2 quartile for both cardiology and pathology, indicating its significant impact and relevance in these disciplines. The journal offers a platform for innovative studies, reviews, and clinical insights, aiming to enhance our understanding of cardiovascular conditions and their pathological underpinnings. With an H-index that showcases its scholarly influence, CARDIOVASCULAR PATHOLOGY is committed to advancing the field through rigorous peer review and open dialogue among professionals. The journal is accessible through institutional subscriptions, making it an essential reference point for ongoing research through its convergence of knowledge from 1992 through 2024.
EXPERIMENTAL AND MOLECULAR PATHOLOGY
Pioneering research for a healthier tomorrow.EXPERIMENTAL AND MOLECULAR PATHOLOGY, a distinguished journal published by Academic Press Inc Elsevier Science, is recognized for its significant contributions to the fields of pathology, clinical biochemistry, and molecular biology. With an ISSN of 0014-4800 and an E-ISSN of 1096-0945, this journal provides a platform for the dissemination of high-quality research articles, reviews, and experimental studies that deepen our understanding of disease mechanisms and diagnostic pathways. Since its inception in 1962 and through its converged publication years, the journal has consistently maintained a solid impact in the academic community, achieving high Scopus rankings—ranked #15 in the field of Pathology and Forensic Medicine and #22 in Clinical Biochemistry, showcasing a commendable percentile standing of 93rd and 81st respectively in 2023. The journal is accessible through various academic libraries and institutional subscriptions, making it an essential resource for researchers, professionals, and students committed to advancing knowledge in these critical areas. With a categorization that includes Q1 rankings in Pathology and Forensic Medicine, EXPERIMENTAL AND MOLECULAR PATHOLOGY stands as a prominent venue for pioneering scientific inquiry and collaborative advancement in molecular diagnostics and therapeutic strategies.
HISTOLOGY AND HISTOPATHOLOGY
Advancing the Frontiers of Tissue ScienceHISTOLOGY AND HISTOPATHOLOGY, published by F HERNANDEZ, is an esteemed academic journal dedicated to advancing the fields of histology and pathology. With its ISSN 0213-3911 and E-ISSN 1699-5848, this journal has been a crucial resource for researchers and professionals since its inception in 1986. The journal enjoys a strong reputation, evidenced by its Q2 category rankings in both Histology and Pathology & Forensic Medicine as of 2023, positioning it within the top tier of scholarly publications. With Scopus rankings placing it at Rank #74/208 in Medicine - Pathology and Forensic Medicine and Rank #31/62 in Medicine - Histology, it proves to be an essential platform for disseminating significant research findings and innovations. Although the journal is not open access, it is committed to providing high-quality, peer-reviewed articles that cater to the needs of its academic community. With a focus on fostering a deeper understanding of tissue structure and disease mechanisms, HISTOLOGY AND HISTOPATHOLOGY serves as an indispensable resource for students, researchers, and practitioners alike, facilitating the exchange of knowledge and pioneering research in these vital areas of study.
JOURNAL OF PATHOLOGY
Elevating Standards in Pathological ScholarshipWelcome to the Journal of Pathology, a premier academic publication specializing in the field of pathology and forensic medicine. Established in 1969 and published by Wiley, this journal has garnered significant recognition within the research community, reflected in its impressive ranking of #6 out of 208 in Scopus, placing it in the 97th percentile. The Journal of Pathology serves as a critical platform for disseminating cutting-edge research findings, innovative methodologies, and topical reviews that advance our understanding of diseases and their underlying mechanisms. With no open access charge, this esteemed journal is committed to maintaining the highest standards of scientific rigor and integrity. As a Q1 journal in its category for 2023, it continues to shape the field of pathology and contribute invaluable insights to researchers, medical professionals, and students alike. We invite you to explore the wealth of knowledge encapsulated in each issue and engage with the vibrant discussions that strive to propel the science of pathology forward.
NAR Cancer
Elevating cancer research to global heights.NAR Cancer, published by Oxford University Press, is a pioneering open access journal established to advance the rapidly evolving field of cancer research. Since its inception in 2019, this journal has gained substantial recognition, achieving a prestigious Q1 ranking in both Cancer Research and Oncology categories as of 2023. With a focused objective to disseminate high-quality research, reviews, and insights into innovative cancer treatments and diagnostics, NAR Cancer serves as an essential platform for researchers, healthcare professionals, and students alike. The journal is accessible for all since it became open access in 2020, ensuring a global reach and impact. Positioned in the competitive landscape of oncology, with impressive Scopus rankings, it offers a unique opportunity for contributors to share their work with an engaged and interdisciplinary audience. With a commitment to excellence, NAR Cancer is dedicated to driving forward the understanding and management of cancer worldwide.
Oral & Maxillofacial Pathology Journal
Enhancing Patient Care with Cutting-Edge DiscoveriesOral & Maxillofacial Pathology Journal is a prominent peer-reviewed publication dedicated to advancing the field of oral and maxillofacial pathology. Published by the KAIRALI SOCIETY OF ORAL & MAXILLOFACIAL PATHOLOGISTS, this journal aims to provide a platform for sharing innovative research, clinical practices, and new techniques related to the diagnosis and management of oral diseases. With a commitment to open access, it ensures that valuable knowledge reaches a global audience of researchers, dental professionals, and students alike. Although specific impact metrics such as the HIndex and Scopus ranking are not listed, the journal is regarded as an essential resource for those involved in the oral health community. It plays a crucial role in fostering collaboration and disseminating cutting-edge advancements that can enhance patient care and clinical outcomes in oral pathology. For professionals looking to stay ahead in this dynamic field, Oral & Maxillofacial Pathology Journal serves as an indispensable tool for both foundational learning and advanced research.
Turkish Journal of Pathology
A Vital Resource for Pathology Professionals WorldwideTurkish Journal of Pathology, published by the Federation Turkish Pathology Society, stands as a vital platform for disseminating high-quality research in the field of pathology and forensic medicine. With an ISSN of 1018-5615 and an E-ISSN of 1309-5730, this journal has been an open-access publication since 2013, ensuring that cutting-edge findings are readily available to the global community. Based in Turkey, it aims to contribute significantly to the advancement of pathology as it converges from 2010 to 2024, currently holding a Q3 quartile ranking in its category according to 2023 metrics. As it ranks #129 out of 208 in the Scopus database for Medicine, Pathology, and Forensic Medicine, it offers researchers, professionals, and students invaluable insights and innovative studies that address critical developments in the field. The Turkish Journal of Pathology fosters collaboration and knowledge-sharing, making it an essential resource for anyone involved in pathology research and practice.
PATHOLOGY & ONCOLOGY RESEARCH
Transforming Understanding in Pathology and OncologyPATHOLOGY & ONCOLOGY RESEARCH is a prominent international journal published by FRONTIERS MEDIA SA, dedicated to advancing the fields of pathology and oncology. Operating from the Netherlands, with a distinguished address in Switzerland, this journal plays a crucial role in disseminating significant research findings and insights from 1995 to 2024. With an ISSN of 1219-4956 and E-ISSN of 1532-2807, it is indexed in well-respected databases, facilitating access to a global audience of researchers and practitioners. Notably, the journal ranks in the Q3 category for Cancer Research (2023), while being recognized in the Q2 categories for both Medicine (Miscellaneous), Oncology, and Pathology and Forensic Medicine, reflecting its authoritative status in these vital disciplines. Scopus rankings further highlight its influence, with notable percentiles across various fields. Although it follows a subscription model, the journal remains committed to publishing high-quality, peer-reviewed research that bridges conceptual gaps and encourages further exploration in oncology and diagnostic pathology, making it an indispensable resource for academics and professionals engaged in these critical areas of medicine.
APMIS
Pioneering Research for the Future of Medical ScienceAPMIS is a distinguished academic journal published by WILEY that serves as a vital resource for researchers and practitioners in the fields of Immunology, Allergy, Microbiology, and Pathology. Established in 1988 and continuing its mission through 2024, this journal facilitates the dissemination of high-quality research findings, contributing to the intersection of multiple disciplines within the medical sciences. With an ISSN of 0903-4641 and an E-ISSN of 1600-0463, APMIS is categorized in 2023's Q2 and Q3 quartiles across various domains, reflecting its significant impact, with rankings such as #50/208 in Pathology and Forensic Medicine and #121/233 in Immunology and Allergy. Although it currently does not offer open access options, the journal’s rigorous peer-review process ensures that published articles maintain the highest standards of scholarship. With its focus on innovative research, APMIS continues to occupy a pivotal role for those seeking to advance their expertise and contribute to scientific dialogue in these essential fields.